Iovance Biotherapeutics
IOVA
IOVA
81 hedge funds and large institutions have $361M invested in Iovance Biotherapeutics in 2017 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 31 increasing their positions, 25 reducing their positions, and 6 closing their positions.
Holders
81
Holders Change
-6
Holders Change %
-6.9%
% of All Funds
2.02%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
5
Increased
31
Reduced
25
Closed
6
Calls
$1.19M
Puts
$139K
Net Calls
+$1.06M
Net Calls Change
+$2.02M
Top Buyers
1 |
1
BlackRock
New York
|
$45.2M |
2 |
GTC
2
Ghost Tree Capital
New York
|
$8.94M |
3 |
3
Goldman Sachs
New York
|
$1.9M |
4 |
4
Victory Capital Management
San Antonio,
Texas
|
$18.9M |
5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$3.73M |